Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $18.14 in the prior trading day, NovoCure Ltd (NASDAQ: NVCR) closed at $17.95, down -1.05%. In other words, the price has decreased by -$1.05 from its previous closing price. On the day, 0.87 million shares were traded. NVCR stock price reached its highest trading level at $18.4 during the session, while it also had its lowest trading level at $17.47.
Ratios:
Our goal is to gain a better understanding of NVCR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.41 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 1.92 whereas as Long-Term Debt/Eq ratio is at 0.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on December 02, 2024, Upgraded its rating to Outperform and sets its target price to $30 from $18 previously.
On October 16, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $24 to $30.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when Weinberg Uri sold 268 shares for $18.92 per share. The transaction valued at 5,071 led to the insider holds 166,243 shares of the business.
Leonard Frank X sold 2,527 shares of NVCR for $46,841 on Mar 03 ’25. The EVP, Pres., Novocure Oncology now owns 143,673 shares after completing the transaction at $18.54 per share. On Mar 03 ’25, another insider, Cordova Ashley, who serves as the Chief Executive Officer of the company, sold 2,053 shares for $18.54 each. As a result, the insider received 38,055 and left with 204,005 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVCR now has a Market Capitalization of 2001173760 and an Enterprise Value of 1768766080. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.22 while its Price-to-Book (P/B) ratio in mrq is 5.53. Its current Enterprise Value per Revenue stands at 2.845 whereas that against EBITDA is -11.522.
Stock Price History:
The Beta on a monthly basis for NVCR is 0.73, which has changed by 0.21447897 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, NVCR has reached a high of $34.13, while it has fallen to a 52-week low of $12.17. The 50-Day Moving Average of the stock is -3.19%, while the 200-Day Moving Average is calculated to be -12.03%.
Shares Statistics:
The stock has traded on average 904.13K shares per day over the past 3-months and 992090 shares per day over the last 10 days, according to various share statistics. A total of 111.48M shares are outstanding, with a floating share count of 99.75M. Insiders hold about 10.53% of the company’s shares, while institutions hold 85.01% stake in the company. Shares short for NVCR as of 1744675200 were 5136017 with a Short Ratio of 5.68, compared to 1741910400 on 5399415. Therefore, it implies a Short% of Shares Outstanding of 5136017 and a Short% of Float of 7.290000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
